Found: 9
Select item for more details and to access through your institution.
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 3, p. 647, doi. 10.1007/s00432-021-03870-6
- By:
- Publication type:
- Article
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 3989, doi. 10.3390/jcm9123989
- By:
- Publication type:
- Article
Sex-specific differences in physiological parameters related to SARS-CoV-2 infections among a national cohort (COVI-GAPP study).
- Published in:
- PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0292203
- By:
- Publication type:
- Article
Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI-GAPP Study.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 13, p. 2167, doi. 10.3390/diagnostics13132167
- By:
- Publication type:
- Article
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA).
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 8, p. 593, doi. 10.3390/diagnostics10080593
- By:
- Publication type:
- Article
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies.
- Published in:
- Disease Markers, 2021, p. 1, doi. 10.1155/2021/8810196
- By:
- Publication type:
- Article
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/9878453
- By:
- Publication type:
- Article
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 1, p. e49, doi. 10.1515/cclm-2020-1347
- By:
- Publication type:
- Article
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2020, v. 58, n. 12, p. 2131, doi. 10.1515/cclm-2020-0978
- By:
- Publication type:
- Article